Phaco vs. Phaco-ELT vs. Phaco-Trabectome 12m

NCT ID: NCT01194310

Last Updated: 2017-07-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

245 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-01-01

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares efficacy (i.e. IOP and hypotensive medications) of phaco alone vs. combined phaco plus excimer laser trabeculotomy vs. combined phaco plus trabectome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Glaucoma is one of the most common reasons for blindness. Usually an elevated drain resistance is the reason, while aqueous humor production is normal. Medical reduction of intraocular pressure (IOP) is first line therapy in most cases. The gold standard of surgical treatment still is trabeculectomy (TE) but TE has a lot of drawbacks. In particular when glaucoma and cataract coexists, the investigators therefore prefer the combined procedure cataract extraction plus excimer laser trabeculotomy (ELT) or plus Trabectome. Indication is cataract and a moderate elevated IOP without medical therapy or a moderate cataract and elevated IOP with medical therapy.

The ELT is performed by an AIDA XeCl-Excimer Laser System (TUI-Laser AG, Germering, 1,2 mJ per burst, burst duration 16 ns, wave length 308 nm, spot diameter 200 µm). 10 foramina were made over 90 degrees of the anterior chamber angle. Trabectome procedure is performed with the Trabectome unit from Neomedix.

* Trial with medical device
* Trial with surgical intervention

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

phaco alone

patients w/ diagnosis of open angle glaucoma underwent phaco alone

phaco

Intervention Type PROCEDURE

Standard clear cornea phacoemulsification plsu intraocular lens Implantation (phaco) alone

phaco-ELT

patients w/ diagnosis of open angle glaucoma underwent combined phaco plus ELT

phaco

Intervention Type PROCEDURE

Standard clear cornea phacoemulsification plsu intraocular lens Implantation (phaco) alone

phaco-ELT

Intervention Type PROCEDURE

Standard clear cornea phacoemulsification plsu intraocular lens Implantation (phaco) plus excimer laser trabeculotomy (ELT)

phaco-Trabectome

patients w/ diagnosis of open angle glaucoma underwent combined phaco plus Trabectome

phaco

Intervention Type PROCEDURE

Standard clear cornea phacoemulsification plsu intraocular lens Implantation (phaco) alone

phaco-Trabectome

Intervention Type PROCEDURE

Standard clear cornea phacoemulsification plsu intraocular lens Implantation (phaco) plus Trabectome

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

phaco

Standard clear cornea phacoemulsification plsu intraocular lens Implantation (phaco) alone

Intervention Type PROCEDURE

phaco-ELT

Standard clear cornea phacoemulsification plsu intraocular lens Implantation (phaco) plus excimer laser trabeculotomy (ELT)

Intervention Type PROCEDURE

phaco-Trabectome

Standard clear cornea phacoemulsification plsu intraocular lens Implantation (phaco) plus Trabectome

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients, which had Phaco, Phako/ELT, or Phaco-Trabectome from 01/2008 until 12/2011, where screened 12 month after surgery

Exclusion Criteria

* IOP \>35 mmHg
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

01 Studienregister MasterAdmins

Role: STUDY_DIRECTOR

UniversitaetsSpital Zuerich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Toteberg-Harms M, Hanson JV, Funk J. Cataract surgery combined with excimer laser trabeculotomy to lower intraocular pressure: effectiveness dependent on preoperative IOP. BMC Ophthalmol. 2013 Jun 24;13:24. doi: 10.1186/1471-2415-13-24.

Reference Type DERIVED
PMID: 23799932 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Phako/ELT/Trabectome-12m

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.